Get the Stockscreener App
47.64
0.76%
0.36
After Hours:
47.15
-0.49
-1.03%
Anbio Biotechnology stock is traded at $47.64, with a volume of 44,509.
It is up +0.76% in the last 24 hours and up +11.86% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$47.28
Open:
$47.3
24h Volume:
44,509
Relative Volume:
0.34
Market Cap:
$2.09B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+14.86%
1M Performance:
+11.86%
6M Performance:
+637.46%
1Y Performance:
+0.00%
1-Day Range:
$46.80
$49.50
1-Week Range:
$41.59
$49.50
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
47.64 | 2.00B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
454.52 | 168.15B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
191.26 | 53.93B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.81 | 39.68B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.91 | 38.70B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
247.54 | 17.53B | 2.96B | 487.70M | 344.00M | 6.68 |
Anbio Biotechnology Stock (NNNN) Latest News
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is AMZE showing signs of accumulationEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Sentiment Turns Positive on ASGN Incorporated — Reversal AheadWeekly Stock Report & Daily Momentum Trading Reports - beatles.ru
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & High Conviction Investment Ideas - Newser
Are Bears Losing Grip on BLFS? getLinesFromResByArray error: size == 0 - 더경남뉴스
Analyzing Share Issuance and Voting Rights Dynamics in Growth-Stage Biotechs: Navigating Governance and Dilution Risks - AInvest
What earnings revisions data tells us about iBio Inc.2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
LKY(linkey) Project ReviewTrade Exit Summary & Safe Entry Zone Identification - Newser
Is ACCESS Newswire Inc. forming a bottoming base2025 Year in Review & Expert Verified Movement Alerts - Newser
Real time breakdown of Graham Holdings Company stock performance2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Is ZVIA stock poised for growthDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Technical signs of recovery in Fortive Corporation2025 Big Picture & Technical Entry and Exit Alerts - Newser
How High Can FHE(mind network) Go2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Will Grayscale Ethereum Trust outperform the marketJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Live market analysis of HJJ CLMarket Movement Recap & Verified Technical Signals - Newser
Top Reasons to Buy PIX(pixelswap)July 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
What recovery options are there for RGC Resources Inc.Market Growth Review & Fast Exit and Entry Trade Guides - Newser
Arista Networks Volume Dives 27.46 to 97th Rank Amid Record Earnings and Analyst Upgrades - AInvest
Why Rapid7 Inc. stock attracts strong analyst attention2025 Sector Review & Risk Adjusted Buy/Sell Alerts - Newser
Is Greenland Technologies Holding Corporation’s ROE strong enoughRate Hike & Weekly High Conviction Trade Ideas - sundaytimes.kr
Should you hold or exit HONE nowLayoff News & Accurate Buy Signal Notifications - Newser
Can machine learning forecast TMUS recoveryEarnings Beat & Technical Buy Zone Confirmation - Newser
How do analysts view the current valuation of Nasdaq stocks? - AInvest
News impact scoring models applied to Cmb.Tech NVWall Street Watch & Daily Profit Focused Screening - Newser
How to read the order book for STRRPMarket Movers & Real-Time Chart Breakout Alerts - Newser
Leading vs lagging indicators on ETI.PR performanceFed Meeting & High Accuracy Swing Entry Alerts - Newser
The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest
Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest
Anbio Biotechnology Class A Ordinary Shares Subject to Lock-Up Agreement Ending August 18, 2025. - AInvest
Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Certain Class A Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser
Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest
Will The Southern Company Preferred Security benefit from macro trendsMulti-Year Signal Summary and Entry Timing - Newser
enCore Energy Corp. stock prediction for this weekFree ROI Boosting Trade Opportunity Calendar - Newser
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - digitalmore.co
Elegoo Launches Nexprint Million-Dollar Creator Fund to Reward Original Content - digitalmore.co
Anbio Biotechnology's Strategic Expansion into Point-of-Care Diagnostics: A High-Growth Opportunity in Global Infectious Disease Management - AInvest
Breakthrough: Anbio's 15-Minute PCR System and Chikungunya Test Transform Disease Detection - Stock Titan
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewswire Inc.
Why Coherus BioSciences Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
Full technical analysis of AFSC stockEarnings Based Stock Performance Forecast - Newser
Anbio Biotechnology (NNNN) Surges 13% in Dramatic Intraday Rally – What’s Fueling the Momentum? - AInvest
7 healthtech scaleups to watch in Europe & UK in 2025 - Tech Funding News
Is FORR stock bottoming outCapital Growth Plan for New Investors - Newser
Will Intuitive Machines Inc. stock recover after recent dropIntraday Movement Recap and Chart Summary - Newser
IRBT stock daily chart insightsDownside Control Plan With Support Analysis - Newser
Why UGRO stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser
BAC.PRCC stock prediction for this weekFree Smart Money Tracking Signal Generator - Newser
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.77%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):